K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 8,105.00% | 213.14% | -758.10% | 142.04% | 95.57% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.74% | -187.80% | -4,340.00% | -38,350.00% | -5,345.16% |
| Change in Net Operating Assets | 32.22% | -128.37% | -413.49% | 239.88% | -2,123.98% |
| Cash from Operations | 26.32% | -129.47% | -477.97% | 149.77% | -61,356.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -175.00% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 188.68% | 42.23% | 47.47% | 145.37% | 41.91% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -85.79% | 85.79% |
| Cash from Financing | -18.37% | 41.78% | 80.24% | 8.95% | 1,165.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.54% | -161.01% | -1,132.83% | 327.10% | 0.67% |
